Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Current Leases: 2019-2022

Historic Current Leases for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $1.1 million.

  • ADC Therapeutics' Current Leases rose 69.70% to $1.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.4 million, marking a year-over-year increase of 69.70%. This contributed to the annual value of $1.1 million for FY2022, which is 6.61% up from last year.
  • As of FY2022, ADC Therapeutics' Current Leases stood at $1.1 million, which was up 6.61% from $1.0 million recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Current Leases registered a high of $1.1 million during FY2022, and its lowest value of $924,000 during FY2019.
  • For the 2-year period, ADC Therapeutics' Current Leases averaged around $1.1 million, with its median value being $1.1 million (2021).
  • Data for ADC Therapeutics' Current Leases shows a peak YoY rose of 6.61% (in 2022) over the last 5 years.
  • ADC Therapeutics' Current Leases (Yearly) stood at $924,000 in 2019, then reached $1.0 million in 2021, then increased by 6.61% to $1.1 million in 2022.